• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒性休克患者行连续性静脉-静脉血液滤过治疗后血浆犬尿氨酸浓度的变化。

Changes in plasma kynurenic acid concentration in septic shock patients undergoing continuous veno-venous haemofiltration.

机构信息

Department of Anaesthesiology and Intensive Therapy, Medical University of Lublin, Jaczewskiego Street 8, 20-954, Lublin, Poland,

出版信息

Inflammation. 2014 Feb;37(1):223-34. doi: 10.1007/s10753-013-9733-9.

DOI:10.1007/s10753-013-9733-9
PMID:24043287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3929023/
Abstract

Kynurenic acid (KYNA) is one of the end products of tryptophan metabolism. The aim of this study was to analyse plasma KYNA concentration in septic shock patients (SSP) with acute kidney injury (AKI) undergoing continuous veno-venous haemofiltration (CVVH). Changes in KYNA content were compared to alterations in the levels of procalcitonin (PCT), C-reactive protein and lactate. Adult SSP with AKI were examined. Measurements were conducted at seven time points: before beginning CVVH and at 6, 12, 24, 48, 72 and 96 h after the beginning of CVVH. Based on clinical outcomes, the data were analysed separately for survivors and non-survivors. Twenty-seven patients were studied. CVVH was associated with reduced plasma KYNA concentration only in survivors. Plasma KYNA concentration correlated with the levels of lactate and PCT only in survivors. (1) CVVH reduced plasma KYNA concentration only in survivors; (2) lack of this reduction may predict fatal outcomes in SSP.

摘要

犬尿氨酸(KYNA)是色氨酸代谢的终产物之一。本研究旨在分析行连续性静脉-静脉血液滤过(CVVH)的伴有急性肾损伤(AKI)的脓毒性休克患者(SSP)的血浆 KYNA 浓度。将 KYNA 含量的变化与降钙素原(PCT)、C 反应蛋白和乳酸水平的变化进行比较。对伴有 AKI 的成年 SSP 进行检查。在七个时间点进行测量:开始 CVVH 前和开始 CVVH 后 6、12、24、48、72 和 96 小时。根据临床结果,对存活者和非存活者的数据分别进行分析。共研究了 27 名患者。仅在存活者中,CVVH 与血浆 KYNA 浓度降低相关。仅在存活者中,血浆 KYNA 浓度与乳酸和 PCT 水平相关。(1)CVVH 仅在存活者中降低血浆 KYNA 浓度;(2)这种降低的缺乏可能预测 SSP 的致命结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b6a/3929023/1e72116022f5/10753_2013_9733_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b6a/3929023/1e72116022f5/10753_2013_9733_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b6a/3929023/1e72116022f5/10753_2013_9733_Fig1_HTML.jpg

相似文献

1
Changes in plasma kynurenic acid concentration in septic shock patients undergoing continuous veno-venous haemofiltration.脓毒性休克患者行连续性静脉-静脉血液滤过治疗后血浆犬尿氨酸浓度的变化。
Inflammation. 2014 Feb;37(1):223-34. doi: 10.1007/s10753-013-9733-9.
2
Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.脓毒性休克合并急性少尿性肾衰竭患者持续静静脉血液滤过期间降钙素原的物质转运、清除率及血浆浓度
Crit Care. 2003 Dec;7(6):R160-6. doi: 10.1186/cc2372. Epub 2003 Oct 2.
3
Elimination of procalcitonin and plasma concentrations during continuous veno-venous haemodiafiltration in septic patients.脓毒症患者持续静-静脉血液透析滤过过程中降钙素原的清除及血浆浓度变化
Eur J Anaesthesiol. 2000 Nov;17(11):665-71. doi: 10.1046/j.1365-2346.2000.00758.x.
4
Diagnostic and prognostic value of procalcitonin in patients with septic shock.降钙素原在感染性休克患者中的诊断及预后价值
Crit Care Med. 2004 May;32(5):1166-9. doi: 10.1097/01.ccm.0000126263.00551.06.
5
Procalcitonin as a marker of severity in septic shock.降钙素原作为脓毒性休克严重程度的标志物。
Langenbecks Arch Surg. 1999 Feb;384(1):33-8. doi: 10.1007/s004230050170.
6
C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia.C 反应蛋白和降钙素原作为呼吸机相关性肺炎患者生存和感染性休克的预测因子。
Eur Respir J. 2010 Apr;35(4):805-11. doi: 10.1183/09031936.00051309. Epub 2009 Aug 28.
7
Serum procalcitonin is a sensitive marker for septic shock and mortality in secondary peritonitis.血清降钙素原是继发性腹膜炎中感染性休克和死亡率的敏感标志物。
Anaesthesiol Intensive Ther. 2014 Sep-Oct;46(4):262-73. doi: 10.5603/AIT.2014.0043.
8
Procalcitonin in patients with acute and chronic renal insufficiency.急性和慢性肾功能不全患者的降钙素原
Wien Klin Wochenschr. 2004 Dec 30;116(24):849-53. doi: 10.1007/s00508-004-0279-6.
9
Continuous veno-venous hemofiltration to adjust fluid volume excess in septic shock patients reduces intra-abdominal pressure.连续性静脉-静脉血液滤过用于调节感染性休克患者的液体量超负荷,可降低腹腔内压力。
Clin Nephrol. 2014 Jul;82(1):41-50. doi: 10.5414/CN108015.
10
A pilot study of high-adsorption hemofiltration in human septic shock.高吸附血液滤过治疗人感染性休克的一项初步研究。
Int J Artif Organs. 2007 Feb;30(2):108-17. doi: 10.1177/039139880703000205.

引用本文的文献

1
Kynurenine Pathway after Kidney Transplantation: Friend or Foe?肾脏移植后的犬尿氨酸途径:是敌是友?
Int J Mol Sci. 2024 Sep 14;25(18):9940. doi: 10.3390/ijms25189940.
2
Prognostic biomarkers for sepsis mortality based on the literature and LC-MS-based metabolomics of sepsis patients.基于文献及脓毒症患者的液相色谱-质谱联用代谢组学的脓毒症死亡率预后生物标志物
Am J Transl Res. 2023 Sep 15;15(9):5757-5768. eCollection 2023.
3
Identification of Biomarkers for the Diagnosis of Sepsis-Associated Acute Kidney Injury and Prediction of Renal Recovery in the Intensive Care Unit.

本文引用的文献

1
A combined epidemiologic and metabolomic approach improves CKD prediction.联合流行病学和代谢组学方法可提高 CKD 预测能力。
J Am Soc Nephrol. 2013 Jul;24(8):1330-8. doi: 10.1681/ASN.2012101006. Epub 2013 May 16.
2
Plasma kynurenic acid/tryptophan ratio: a sensitive and reliable biomarker for the assessment of renal function.血浆犬尿氨酸/色氨酸比值:评估肾功能的敏感可靠生物标志物。
Ren Fail. 2013;35(5):648-53. doi: 10.3109/0886022X.2013.790301. Epub 2013 May 7.
3
N-methyl-D-aspartate receptor antagonist therapy suppresses colon motility and inflammatory activation six days after the onset of experimental colitis in rats.
用于诊断脓毒症相关性急性肾损伤和预测重症监护病房中肾功能恢复的生物标志物的鉴定。
Yonsei Med J. 2023 Mar;64(3):181-190. doi: 10.3349/ymj.2022.0324.
4
The influence of cyclooxygenase inhibitors on kynurenic acid production in rat kidney: a novel path for kidney protection?环氧化酶抑制剂对大鼠肾脏犬尿氨酸生成的影响:肾脏保护的新途径?
Pharmacol Rep. 2023 Apr;75(2):376-385. doi: 10.1007/s43440-023-00460-w. Epub 2023 Feb 14.
5
Kynurenine Pathway-An Underestimated Factor Modulating Innate Immunity in Sepsis-Induced Acute Kidney Injury?犬尿氨酸途径——调节脓毒症诱导的急性肾损伤固有免疫的被低估因素?
Cells. 2022 Aug 21;11(16):2604. doi: 10.3390/cells11162604.
6
Metabolomic profiling demonstrates evidence for kidney and urine metabolic dysregulation in a piglet model of cardiac surgery-induced acute kidney injury.代谢组学分析表明,在心脏手术引起的急性肾损伤的仔猪模型中,肾脏和尿液代谢失调的证据。
Am J Physiol Renal Physiol. 2022 Jul 1;323(1):F20-F32. doi: 10.1152/ajprenal.00039.2022. Epub 2022 May 9.
7
Evaluation of Metabolic Changes in Acute Intermittent Porphyria Patients by Targeted Metabolomics.基于靶向代谢组学的急性间歇性卟啉症患者代谢变化评估。
Int J Mol Sci. 2022 Mar 16;23(6):3219. doi: 10.3390/ijms23063219.
8
The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease.犬尿氨酸途径在急性肾损伤和慢性肾脏病中的作用。
Am J Nephrol. 2021;52(10-11):771-787. doi: 10.1159/000519811. Epub 2021 Nov 9.
9
Kynurenine pathway in kidney diseases.色氨酸代谢途径与肾脏疾病。
Pharmacol Rep. 2022 Feb;74(1):27-39. doi: 10.1007/s43440-021-00329-w. Epub 2021 Oct 6.
10
Association between admission serum procalcitonin and the occurrence of acute kidney injury in patients with septic shock: A retrospective cohort study.血清降钙素原与脓毒性休克患者急性肾损伤发生的相关性:一项回顾性队列研究。
Sci Prog. 2021 Jul-Sep;104(3):368504211043768. doi: 10.1177/00368504211043768.
N-甲基-D-天冬氨酸受体拮抗剂治疗可抑制实验性结肠炎大鼠发病后 6 天的结肠蠕动和炎症激活。
Eur J Pharmacol. 2012 Sep 15;691(1-3):225-34. doi: 10.1016/j.ejphar.2012.06.044. Epub 2012 Jul 14.
4
Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems.重症监护患者的胃肠功能:术语、定义和管理。ESICM 腹部问题工作组的建议。
Intensive Care Med. 2012 Mar;38(3):384-94. doi: 10.1007/s00134-011-2459-y. Epub 2012 Feb 7.
5
Flavivirus infection induces indoleamine 2,3-dioxygenase in human monocyte-derived macrophages via tumor necrosis factor and NF-κB.黄病毒感染通过肿瘤坏死因子和 NF-κB 诱导人单核细胞来源的巨噬细胞中的吲哚胺 2,3-双加氧酶。
J Leukoc Biol. 2012 Apr;91(4):657-66. doi: 10.1189/jlb.1011532. Epub 2012 Feb 1.
6
Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection.色氨酸代谢通路抑制作为神经保护的一种治疗策略。
FEBS J. 2012 Apr;279(8):1386-97. doi: 10.1111/j.1742-4658.2012.08487.x. Epub 2012 Mar 27.
7
Effects of pro-inflammatory cytokines on expression of kynurenine pathway enzymes in human dermal fibroblasts.促炎细胞因子对人真皮成纤维细胞犬尿氨酸通路酶表达的影响。
J Inflamm (Lond). 2011 Oct 8;8:25. doi: 10.1186/1476-9255-8-25.
8
The kynurenine system and immunoregulation.犬尿氨酸系统与免疫调节。
J Neural Transm (Vienna). 2012 Feb;119(2):197-209. doi: 10.1007/s00702-011-0681-y. Epub 2011 Jul 9.
9
Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-α (TNF-α) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils.不同的抑制作用的犬尿氨酸酸和一种新的犬尿氨酸酸类似物对单核细胞产生肿瘤坏死因子-α (TNF-α)、单核细胞产生高迁移率族蛋白 B1 (HMGB1)和中性粒细胞分泌中性粒细胞蛋白酶 1-3 (HNP1-3)。
Naunyn Schmiedebergs Arch Pharmacol. 2011 May;383(5):447-55. doi: 10.1007/s00210-011-0605-2. Epub 2011 Feb 19.
10
Tryptophan degradation and serum neopterin concentrations in intensive care unit patients.重症监护病房患者色氨酸降解和血清新蝶呤浓度。
Toxicol Mech Methods. 2011 Mar;21(3):231-5. doi: 10.3109/15376516.2010.545960. Epub 2011 Jan 20.